Clinical development of Modified Vaccinia virus Ankara vaccines.
The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...
Huvudupphovsman: | Gilbert, S |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2013
|
Liknande verk
Liknande verk
-
Clinical development of Modified Vaccinia virus Ankara vaccines
av: Gilbert, S
Publicerad: (2013) -
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
av: Olga Vladimirovna Orlova, et al.
Publicerad: (2022-09-01) -
Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
av: Gilbert, S, et al.
Publicerad: (1999) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
av: Moorthy, V, et al.
Publicerad: (2003) -
Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
av: Kaïdre Bendjama, et al.
Publicerad: (2017-09-01)